位置:首页 > 蛋白库 > UB2J2_MOUSE
UB2J2_MOUSE
ID   UB2J2_MOUSE             Reviewed;         259 AA.
AC   Q6P073; Q8C6A1; Q91Y64; Q9CWY5; Q9DC18; Q9QX58;
DT   13-SEP-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 136.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 J2;
DE            EC=2.3.2.23;
DE   AltName: Full=Non-canonical ubiquitin-conjugating enzyme 2;
DE            Short=NCUBE-2;
GN   Name=Ube2j2; Synonyms=Ncube2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF CYS-94, AND
RP   SUBCELLULAR LOCATION.
RC   STRAIN=C57BL/6J; TISSUE=Fetus;
RX   PubMed=11278356; DOI=10.1074/jbc.m007640200;
RA   Tiwari S., Weissman A.M.;
RT   "Endoplasmic reticulum (ER)-associated degradation of T cell receptor
RT   subunits. Involvement of ER-associated ubiquitin-conjugating enzymes
RT   (E2s).";
RL   J. Biol. Chem. 276:16193-16200(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MUTAGENESIS OF CYS-94, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=12082160; DOI=10.1242/jcs.115.14.3007;
RA   Lenk U., Yu H., Walter J., Gelman M.S., Hartmann E., Kopito R.R.,
RA   Sommer T.;
RT   "A role for mammalian Ubc6 homologues in ER-associated protein
RT   degradation.";
RL   J. Cell Sci. 115:3007-3014(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Lung, and Skin;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION IN CASE OF INFECTION BY THE MURID HERPESVIRUS 4, AND INTERACTION
RP   WITH MURID HERPESVIRUS 4 K3.
RX   PubMed=19951915; DOI=10.1083/jcb.200908036;
RA   Wang X., Herr R.A., Rabelink M., Hoeben R.C., Wiertz E.J., Hansen T.H.;
RT   "Ube2j2 ubiquitinates hydroxylated amino acids on ER-associated degradation
RT   substrates.";
RL   J. Cell Biol. 187:655-668(2009).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
CC   -!- FUNCTION: Catalyzes the covalent attachment of ubiquitin to other
CC       proteins. Seems to function in the selective degradation of misfolded
CC       membrane proteins from the endoplasmic reticulum (ERAD).
CC       {ECO:0000269|PubMed:12082160}.
CC   -!- FUNCTION: In case of infection by the murid herpesvirus 4, its
CC       association with the viral E3 ligase K3 mediates ubiquitination of host
CC       surface class I (MHC-I) H-2D(b)/H2-D1 and H-2K(b)/H2-K1 molecules
CC       before they exit the endoplasmic reticulum, leading to their
CC       degradation by the ERAD system, thus blocking the immune detection of
CC       virus-infected cells. The complex formed with the murid herpesvirus 4
CC       protein K3 mediates ubiquitination of lysine, as well as serine and
CC       threonine residues present in the cytoplasmic tail of surface class I
CC       molecules and promotes ubiquitination of hydroxylated serine or
CC       threonine residues via ester bonds instead of the classical isopeptide
CC       linkage. {ECO:0000269|PubMed:11278356, ECO:0000269|PubMed:19951915}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine +
CC         [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-
CC         activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-
CC         conjugating enzyme]-L-cysteine.; EC=2.3.2.23;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU00388};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with murid herpesvirus 4 protein K3 (mK3).
CC       {ECO:0000269|PubMed:19951915}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:11278356, ECO:0000269|PubMed:12082160}; Single-pass
CC       type IV membrane protein {ECO:0000269|PubMed:11278356,
CC       ECO:0000269|PubMed:12082160}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF296656; AAK52607.1; -; mRNA.
DR   EMBL; U93242; AAF21504.1; -; mRNA.
DR   EMBL; AK004626; BAB23421.1; -; mRNA.
DR   EMBL; AK010302; BAB26835.1; -; mRNA.
DR   EMBL; AK076265; BAC36280.1; -; mRNA.
DR   EMBL; BC065779; AAH65779.1; -; mRNA.
DR   CCDS; CCDS19051.1; -.
DR   RefSeq; NP_001034246.1; NM_001039157.2.
DR   RefSeq; NP_001034247.1; NM_001039158.2.
DR   RefSeq; NP_001034248.1; NM_001039159.2.
DR   RefSeq; NP_001271241.1; NM_001284312.1.
DR   RefSeq; NP_001271243.1; NM_001284314.1.
DR   RefSeq; NP_067377.4; NM_021402.6.
DR   AlphaFoldDB; Q6P073; -.
DR   SMR; Q6P073; -.
DR   BioGRID; 228272; 1.
DR   STRING; 10090.ENSMUSP00000024056; -.
DR   PhosphoSitePlus; Q6P073; -.
DR   EPD; Q6P073; -.
DR   MaxQB; Q6P073; -.
DR   PaxDb; Q6P073; -.
DR   PRIDE; Q6P073; -.
DR   ProteomicsDB; 298166; -.
DR   Antibodypedia; 26182; 144 antibodies from 25 providers.
DR   DNASU; 140499; -.
DR   Ensembl; ENSMUST00000103175; ENSMUSP00000099464; ENSMUSG00000023286.
DR   Ensembl; ENSMUST00000105581; ENSMUSP00000101206; ENSMUSG00000023286.
DR   Ensembl; ENSMUST00000166489; ENSMUSP00000127712; ENSMUSG00000023286.
DR   GeneID; 140499; -.
DR   KEGG; mmu:140499; -.
DR   UCSC; uc007ubh.1; mouse.
DR   CTD; 118424; -.
DR   MGI; MGI:2153608; Ube2j2.
DR   VEuPathDB; HostDB:ENSMUSG00000023286; -.
DR   eggNOG; KOG0894; Eukaryota.
DR   GeneTree; ENSGT00940000156173; -.
DR   InParanoid; Q6P073; -.
DR   OMA; DKMFCEL; -.
DR   OrthoDB; 1230974at2759; -.
DR   Reactome; R-MMU-9609523; Insertion of tail-anchored proteins into the endoplasmic reticulum membrane.
DR   Reactome; R-MMU-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 140499; 3 hits in 74 CRISPR screens.
DR   ChiTaRS; Ube2j2; mouse.
DR   PRO; PR:Q6P073; -.
DR   Proteomes; UP000000589; Chromosome 4.
DR   RNAct; Q6P073; protein.
DR   Bgee; ENSMUSG00000023286; Expressed in spermatocyte and 65 other tissues.
DR   ExpressionAtlas; Q6P073; baseline and differential.
DR   Genevisible; Q6P073; MM.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000151; C:ubiquitin ligase complex; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0061631; F:ubiquitin conjugating enzyme activity; ISO:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0000209; P:protein polyubiquitination; IBA:GO_Central.
DR   GO; GO:0006986; P:response to unfolded protein; IEA:UniProtKB-KW.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; ISO:MGI.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00179; UQ_con; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50127; UBC_2; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Endoplasmic reticulum; Membrane; Nucleotide-binding;
KW   Reference proteome; Transferase; Transmembrane; Transmembrane helix;
KW   Ubl conjugation pathway; Unfolded protein response.
FT   CHAIN           1..259
FT                   /note="Ubiquitin-conjugating enzyme E2 J2"
FT                   /id="PRO_0000082597"
FT   TOPO_DOM        1..226
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        227..247
FT                   /note="Helical; Anchor for type IV membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        248..259
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          12..162
FT                   /note="UBC core"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00388"
FT   ACT_SITE        94
FT                   /note="Glycyl thioester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00388"
FT   MUTAGEN         94
FT                   /note="C->S: Loss of catalytic activity. Slows down
FT                   degradation of misfolded proteins from the ER."
FT                   /evidence="ECO:0000269|PubMed:11278356,
FT                   ECO:0000269|PubMed:12082160"
FT   CONFLICT        25
FT                   /note="K -> T (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        32
FT                   /note="I -> M (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        49
FT                   /note="R -> G (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        80
FT                   /note="M -> I (in Ref. 3; BAB26835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        84
FT                   /note="N -> H (in Ref. 3; BAB26835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        87
FT                   /note="F -> I (in Ref. 3; BAB26835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        133
FT                   /note="E -> K (in Ref. 3; BAB23421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        150
FT                   /note="N -> I (in Ref. 3; BAB26835)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        157
FT                   /note="C -> G (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="E -> K (in Ref. 3; BAB23421)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        186
FT                   /note="L -> W (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        217..218
FT                   /note="AG -> GW (in Ref. 2; AAF21504)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        237
FT                   /note="F -> L (in Ref. 3; BAC36280)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        246
FT                   /note="A -> P (in Ref. 1; AAK52607)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   259 AA;  28954 MW;  0C539BC0ACEAC7C7 CRC64;
     MSNNSNKRAP TTATQRLKQD YLRIKKDPVP YICAEPLPSN ILEWHYVVRG PEMTPYEGGY
     YHGKLIFPRE FPFKPPSIYM ITPNGRFKCN TRLCLSITDF HPDTWNPAWS VSTILTGLLS
     FMVEKGPTLG SIETSDFTKK QLAAQSLVFN LKDKVFCELF PEVVEEIKQK QKAQDELSNR
     PQNLPLPDVV PDGELHRGQH GIQLLNGHAP AAGPNLAGLP QANRHHGLLG GALANLFVIV
     GFAAFAYTVK YVLRSIAQE
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024